SPPI — Spectrum Pharmaceuticals Balance Sheet
0.000.00%
HealthcareSpeculativeSmall Cap
- $211.40m
- $184.11m
- $10.11m
Annual balance sheet for Spectrum Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
C2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 204 | 224 | 180 | 101 | 75.1 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 33.6 | 10 | 2.46 | 1.03 | 13.6 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 251 | 244 | 187 | 104 | 101 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 0.385 | 15.4 | 5.82 | 2.96 | 2.17 |
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 391 | 263 | 197 | 112 | 103 |
| Accounts Payable | |||||
| Payable / Accrued | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 98.3 | 62 | 53.1 | 53.2 | 42.7 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 119 | 73 | 62.6 | 64 | 75.5 |
| Non Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 271 | 190 | 134 | 47.6 | 27.9 |
| Total Liabilities & Shareholders' Equity | 391 | 263 | 197 | 112 | 103 |
| Total Common Shares Outstanding | |||||
| Total Preferred Shares Outstanding |